Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 2
1989 1
1990 2
1991 1
1992 2
1994 1
1995 1
2014 1
2017 1
2021 2
2023 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety.
Luxi N, Giovanazzi A, Capuano A, Crisafulli S, Cutroneo PM, Fantini MP, Ferrajolo C, Moretti U, Poluzzi E, Raschi E, Ravaldi C, Reno C, Tuccori M, Vannacci A, Zanoni G, Trifirò G; Ilmiovaccino COVID19 collaborating group. Luxi N, et al. Drug Saf. 2021 Dec;44(12):1247-1269. doi: 10.1007/s40264-021-01131-6. Epub 2021 Nov 5. Drug Saf. 2021. PMID: 34739716 Free PMC article. Review.
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials.
Ahmadizar F, Luxi N, Raethke M, Schmikli S, Riefolo F, Saraswati PW, Bucsa C, Osman A, Liddiard M, Maques FB, Petrelli G, Sonderlichová S, Thurin NH, Villalobos F, Trifirò G, Sturkenboom M; ilmiovaccinoCOVID19 collaborating group. Ahmadizar F, et al. Drug Saf. 2023 Jun;46(6):575-585. doi: 10.1007/s40264-023-01304-5. Epub 2023 Apr 27. Drug Saf. 2023. PMID: 37103643 Free PMC article.
Post-marketing active surveillance of Guillain Barré Syndrome following COVID-19 vaccination in persons aged ≥12 years in Italy: A multi-database self-controlled case series study.
Morciano C, Spila Alegiani S, Menniti Ippolito F, Belleudi V, Trifirò G, Zanoni G, Puccini A, Sapigni E, Mores N, Leoni O, Monaco G, Clagnan E, Zappetti C, Bovo E, Cutillo M, Da Cas R, Massari M. Morciano C, et al. Among authors: sapigni e. PLoS One. 2024 Jan 19;19(1):e0290879. doi: 10.1371/journal.pone.0290879. eCollection 2024. PLoS One. 2024. PMID: 38241309 Free PMC article.
On the hepatotoxicity of 1,1,2,2-tetrachloroethane.
Paolini M, Sapigni E, Mesirca R, Pedulli GF, Corongiu FP, Dessi MA, Cantelli-Forti G. Paolini M, et al. Among authors: sapigni e. Toxicology. 1992;73(1):101-15. doi: 10.1016/0300-483x(92)90174-d. Toxicology. 1992. PMID: 1317068
Comparing clinical trial population representativeness to real-world users of 17 biologics approved for immune-mediated inflammatory diseases: An external validity analysis of 66,639 biologic users from the Italian VALORE project.
Ingrasciotta Y, Spini A, L'Abbate L, Fiore ES, Carollo M, Ientile V, Isgrò V, Cavazzana A, Biasi V, Rossi P, Ejlli L, Belleudi V, Poggi F, Sapigni E, Puccini A, Ancona D, Stella P, Pollina Addario S, Allotta A, Leoni O, Zanforlini M, Tuccori M, Gini R, Trifirò G. Ingrasciotta Y, et al. Among authors: sapigni e. Pharmacol Res. 2024 Feb;200:107074. doi: 10.1016/j.phrs.2024.107074. Epub 2024 Jan 15. Pharmacol Res. 2024. PMID: 38232909 Free article.
Long term effectiveness on prescribing of two multifaceted educational interventions: results of two large scale randomized cluster trials.
Magrini N, Formoso G, Capelli O, Maestri E, Nonino F, Paltrinieri B, Del Giovane C, Voci C, Magnano L, Daya L, Marata AM; INDRA-NET study group. Magrini N, et al. PLoS One. 2014 Oct 17;9(10):e109915. doi: 10.1371/journal.pone.0109915. eCollection 2014. PLoS One. 2014. PMID: 25329386 Free PMC article. Clinical Trial.
20 results